Abstract: Provided are a prophylactic or therapeutic agent for a peptic ulcer, a food additive for prevention and treatment of a peptic ulcer, an iNOS expression inhibitor, and a COX-2 expression inhibitor, all of which have little side effects. The prophylactic or therapeutic agent contains a Euglena-derived material as an active ingredient. The Euglena-derived material may be Euglena, paramylon, or an acid-treated paramylon. The prophylactic or therapeutic agent is useful for the prevention or treatment of a peptic ulcer induced by psychological stress. The peptic ulcer may be a gastric ulcer. The food additive contains a Euglena-derived material as an active ingredient.

Abstract: The present invention makes it possible to, even when a stainless steel is adopted in a diaphragm: prevent the diaphragm and a strain sensor from exfoliating from each other; be hardly susceptible to the influence of temperature in an operating environment; not allow the sensitivity of a pressure sensor to be dominated only by the mechanical characteristic of a material constituting the diaphragm; and increase the degree of freedom in design of members constituting the pressure sensor.

Abstract: A spectroscopic measurement apparatus includes a light source, an integrator, a spectroscopic detector, and an analysis unit. The integrator includes an internal space in which a measurement object is disposed, a light input portion for inputting light to the internal space, a light output portion for outputting light from the internal space, a sample attachment portion for attaching the measurement object, and a filter attachment portion for attaching a filter unit. The filter unit has a transmission spectrum in which an attenuation rate for excitation light is larger than an attenuation rate for up-conversion light, and attenuates the light output from the light output portion. The analysis unit analyzes luminous efficiency of the measurement object on the basis of the transmission spectrum data and the spectroscopic spectrum data acquired by the spectroscopic detector.

Abstract: A spectroscopic measurement apparatus includes a light source, an integrator, a first spectroscopic detector, a second spectroscopic detector, and an analysis unit. The integrator includes an internal space in which a measurement object is disposed, a light input portion for inputting light to the internal space, a light output portion for outputting light from the internal space, and a sample attachment portion for attaching the measurement object. The first spectroscopic detector receives the light output from the integrator, disperses the light of a first wavelength region, and acquires first spectrum data. The second spectroscopic detector receives the light output from the integrator, disperses the light of a second wavelength region, and acquires second spectrum data. The first wavelength region and the second wavelength region include a wavelength region partially overlapping each other.

Abstract: An electronic device includes a housing having an opening, a connection terminal located in an opening in the housing, and a terminal cover including a first resin member having a first surface facing the connection terminal and a second surface located opposite to the first surface and a second resin member located on the second surface. At least a portion of the second resin member covers a depression located on an outer peripheral portion of the first surface of the first resin member.

Abstract: Provided are a novel renal failure progression inhibitor, prophylactic agent for renal failure, and indoxyl sulfate production inhibitor, intended for human use, in particular, for a patient with renal failure. The renal failure progression inhibitor, prophylactic agent for renal failure, and indoxyl sulfate production inhibitor each comprises paramylon derived from Euglena or a processed product thereof as an active ingredient. In the case of the renal failure progression inhibitor, for example, paramylon is continuously orally administered to a patient suffering from chronic renal failure, undergoing a dialysis therapy, several times per day in a dose of 1 to 5 g per intake. In particular, the renal failure progression inhibitor is singly administered to the patient in a capsule or powdered preparation at a prescribed time interval before and after administration of other drugs.

Abstract: An optical measurement device inputs excitation light to an integrating sphere in which a sample is disposed, irradiates the sample with the excitation light having a predetermined beam cross-section, detects measurement light output from the integrating sphere by a photodetector, and acquires intensity data of the sample. The optical measurement device includes a storage unit in which correction data is stored and an optical characteristic calculation unit for calculating optical characteristics of the sample based on the intensity data of the sample and the correction data. The correction data is calculated based on first corrective intensity data and second corrective intensity data. The predetermined beam cross-section is covered with the first light absorbing member and covers the second light absorbing member.

Abstract: A flexible board includes: a base film, on which a wiring pattern is formed; a first cover film, which is located on one surface of the base film; and a second cover film, which is located on the other surface of the base film. The bending portion, which is bent when mounting the flexible board on an electronic apparatus, includes both edges on which the first cover film is formed and a central portion from which the base film is exposed.

Abstract: A ?-1,3-glucanase that exhibits decomposition activity with respect to paramylon derived from the genus Euglena. The ?-1,3-glucanase is derived from the genus Euglena and exhibits the properties indicated below: (1) effect: hydrolyzing the ?-1,3-bond of ?-1,3-glucan; and (2) substrate specificity: decomposing at least paramylon. The ?-1,3-glucanase additionally exhibits the properties indicated below: (3) decomposition activity: the ratio of paramylon decomposition activity with respect to laminarin decomposition activity is 20% or higher; (4) optimum pH: 3.7-7.0; and (5) optimum temperature: 30-70° C.

Abstract: In a solenoid of a hydraulic pressure control apparatus, a region adjacent to an oil flow guide portion of a stopper breathing passage is formed in a magnetism application region, through which a leakage magnetic flux leaking from a magnetic circuit at a time of turning on of a coil passes. Thereby, magnetic foreign objects made of iron or iron containing material are magnetically attracted to the leakage magnetic flux, so that intrusion of the foreign objects from an outside of the solenoid into a second volume variable chamber through the stopper breathing passage is limited.

Abstract: An algae culture method capable of efficiently producing an osmotic pressure adjusting substance, a production method of the substance, and an algae culture method for recovering carbon dioxide from a mixed gas containing carbon dioxide and sulfurous acid gas. The methods involve preparing a plurality of enrichment cultures each containing betaine by culturing a culture of microalgae derived from an environmental specimen under a photoautotrophic condition and under a plurality of culture conditions; making a cultivation plan in which an optimum enrichment culture suitable for a main culture is selected from the plurality of enrichment cultures; producing a main culture that contains betaine under the photoautotrophic condition and a salt concentration of 10 wt. % or more; and separating betaine. In the main culture, the algae containing betaine are cultured while the mixed gas containing sulfurous acid gas and carbon dioxide is blown to a culture solution of the algae.

Abstract: The present invention provides a novel immune balance regulator that regulates an immune balance in a living body. The immune balance regulator contains a Euglena-derived material and regulates an immune balance between Th1, Th2, and Th17, which is a balance between immune responses individually induced by Th1, Th2, and Th17 in a living body. The immune balance regulator regulates the immune balance between Th1, Th2, and Th17 so that immune responses induced by Th1 become relatively dominant over immune responses induced by Th2 or Th17 to improve a physical constitution that has an immune imbalance of Th1, Th2, and Th17 shifted towards Th2 and to prevent or treat a disease associated with the immune imbalance of Th1, Th2, and Th17 shifted towards a Th2 dominance. The immune balance regulator is administered prior to expected onset of a disease associated with the immune imbalance of Th1, Th2, and Th17 shifted towards the Th2 dominance.

Abstract: There is provided a buildup device that builds up a plate-shaped core after rotating the core by a predetermined angle, and that includes a servomotor, a damping plate attached to the servomotor, at least one upper plate provided above the damping plate, at least one lower plate provided below the damping plate, and a plurality of vibration absorbing members attached to the damping plate. The upper plate and the lower plate restrict a degree of freedom of vibration to one direction, and the vibration absorbing members absorb vertical vibration.

Abstract: A sheet material feeding apparatus includes a first roll 106, and a second roll 108 arranged vertically below first roll 106, to feed a sheet material clamped between the first roll 106 and the second roll 108. The sheet material feeding apparatus further includes a first motor 102 provided with a rotatable first motor shaft 104 coupled to the first roll 106, and a second motor 103 provided with a rotatable second motor shaft 105 coupled to the second roll 108. The first motor shaft 104 and the second motor shaft 105 rotate at substantially the same rotation speed to allow the first roll 106 and the second roll 108 to rotate in synchronization with each other.

Abstract: An electromagnetic valve includes: a housing, a ball valve, a ball guide to hold the ball valve, a shaft that displaces the ball valve; an electromagnetic solenoid part that drives the shaft; a seat component; and a seal member. The seat component has a cylindrical portion disposed inside of the housing, and has a predetermined depth in an axial direction. An inflow valve port passes through a first end of the cylindrical portion in the axial direction. The seal member is coupled with an outer circumference part of the housing at a position corresponding to the cylindrical portion.

Abstract: A medium for culturing Euglena includes a cell membrane-permeable electron mediator that includes a biocompatible moiety and a redox-active moiety. A method for culturing Euglena includes culturing Euglena in a medium including a cell membrane-permeable electron mediator that includes a biocompatible moiety and a redox-active moiety. The medium is placed in a fermenter system that includes a device for extracting electrons from the medium. A method for reducing photoinhibition in Euglena includes electrochemically culturing Euglena in a medium including a cell membrane-permeable electron mediator that includes a biocompatible moiety and a redox-active moiety. The medium is placed in a fermenter system that includes a device for extracting electrons from the medium.

Abstract: A spectral measurement apparatus includes a light source for generating a excitation light; an integrator having an input opening portion and an output opening portion; a housing portion arranged in the integrator and for housing a sample; an incidence optical system for making the excitation light incident to the sample; a photodetector for detecting a light to be measured output from the output opening portion; and an analysis means for calculating a light absorptance of the sample, based on a detection value detected by the photodetector, and an irradiation area with the excitation light at a position of incidence to the sample is set larger than an irradiated area of the sample, and the analysis means performs an area ratio correction regarding the irradiation area with the excitation light and the irradiated area of the sample, with respect to the light absorptance calculated.

Abstract: A ?-1,3-glucanase that exhibits decomposition activity with respect to paramylon derived from the genus Euglena. The ?-1,3-glucanase is derived from the genus Euglena and exhibits the properties indicated below: (1) effect: hydrolyzing the ?-1,3-bond of ?-1,3-glucan; and (2) substrate specificity: decomposing at least paramylon. The ?-1,3-glucanase additionally exhibits the properties indicated below: (3) decomposition activity: the ratio of paramylon decomposition activity with respect to laminarin decomposition activity is 20% or higher; (4) optimum pH: 3.7-7.0; and (5) optimum temperature: 30-70° C.

Abstract: A solenoid device includes a plunger driven in an axial direction, a wall portion arranged to oppose the plunger in the axial direction, and a respiratory pore cover covering an opening of a respiratory pore of the wall portion. A volume variable chamber is defined between the plunger and the wall portion. The respiratory pore cover defines a communication space communicated to the respiratory pore, and an opening which causes the communication space to communicate with an exterior space. A volume of the communication space is larger than a predetermined volume of fluid that flows through the respiratory pore from or into the volume variable chamber by a predetermined movement of the plunger.

Abstract: In the composite substrate 10, the piezoelectric substrate 12 and the support substrate 14 are bonded by direct bonding using an ion beam. One surface of the piezoelectric substrate 12 is a negatively-polarized surface 12a and another surface of the piezoelectric substrate 12 is a positively-polarized surface 12b. An etching rate at which the negatively-polarized surface 12a is etched with a strong acid may be higher than an etching rate at which the positively-polarized surface 12b is etched with the strong acid. The positively-polarized surface 12b of the piezoelectric substrate 12 is directly bonded to the support substrate 14. The negatively-polarized surface 12a of the piezoelectric substrate 12 may be etched with the strong acid.